Healthcare
-
The company plans to expand into the healthcare and biology sectors, positioning medical research as a significant opportunity for AI
Anthropic highlighted the immense potential of AI in healthcare in its IPO filing, including aiding in the treatment of major diseases and accelerating scientific discovery. The company plans to expan
-
According to the Financial Times, U.S. healthcare provider Bon Secours Mercy Health is in advanced talks to acquire a majority stake in Surgery Partners for approximately $6 billion, valuing the latter at around $20 per share.
According to the Financial Times, U.S. healthcare provider Bon Secours Mercy Health is in advanced talks to acquire a majority stake in Surgery Partners for approximately $6 billion, valuing the latte
-
Elevance Health Inc. (ELV) Q3 Earnings Report: EPS of $6.99 beats expectations, revenue of $50.44 billion beats expectations.
EPS: $6.99, market expected $4.71 Revenue: $50.44 billion, market expected $49.22 billion Reporting Period: FY2026 Q3 (ended September 30, 2026) Release Date: October 21, 2026
-
Steris to Acquire Xodus Medical for $2.1 Billion
Dublin, Ireland-based Steris, a provider of products and services to hospitals and pharmaceutical manufacturers, announced its plan to acquire Xodus Medical for $2.1 billion. The company expects the d
-
BlackRock Strategist Gargi Pal Chaudhuri Opposes Fed Hike, Recommends AI, Quality, and Healthcare Themes
BlackRock strategist Gargi Pal Chaudhuri recommends investors stay invested in the artificial-intelligence sector but broaden into themes like quality and healthcare.
-
Yahoo Finance Analysis: State Street XLV Outperforms iShares IXJ in Returns, Offers Lower Fees Despite Less Diversification
Yahoo Finance analysis indicates that the State Street Health Care Select Sector SPDR ETF (XLV), focusing on U.S. healthcare leaders, has outperformed the iShares Global Healthcare ETF (IXJ) in both o
-
Yahoo Finance Analysis: Bristol Myers Squibb (BMY) is a solid buy among healthcare stocks, with a forward yield nearing 4%, as patent cliff fears are deemed overblown.
The analysis notes that despite a major patent cliff, with Eliquis and Opdivo losing U.S. patent exclusivity in 2028, Bristol Myers Squibb's stock appears cheap at under 10 times forward earnings. Ana
-
U.S. Senator Elizabeth Warren's 2026 Bill Proposes Up to 6 Years in Prison for Private Equity Execs Over Patient Deaths
The Corporate Crimes Against Health Care Act of 2026, introduced by Senator Elizabeth Warren and other Democratic lawmakers in February, aims to hold private equity executives criminally liable for fi
-
Advent International seeks more Australia, New Zealand healthcare opportunities after acquiring New Zealand Clinical Research, valued at about $715 million
Advent International seeks more Australia, New Zealand healthcare opportunities after acquiring New Zealand Clinical Research, valued at about $715 million
-
OpenAI's ChatGPT Health Integrates with Epic EHR System
The integration allows clinicians to import patient data for AI queries, providing read-only access to health records without AI writing anything back. This enables clinicians to easily access and sum
-
Asian Healthcare Deals Heat Up as Investors Bet on Brain-Computer Interface and Surgical Robotics Technologies
Asian private investors, including Hong Kong family offices, are increasingly focusing on advanced medical technologies such as brain-computer interfaces and surgical robots. With the booming biotechn
-
Analysis indicates that the Fidelity MSCI Health Care Index ETF (FHLC) has lower fees and is more diversified, while the Invesco Pharmaceuticals ETF (PJP) has shown higher returns in recent years but carries concentrated risk.
An analysis article compared two healthcare ETFs. FHLC tracks a broad range of U.S. healthcare stocks, has lower fees than PJP, and offers a higher dividend yield, with over 300 stock holdings, making
-
Healthcare Stocks Increasingly Trade Opposite to Tech, Showing Negative Correlation with Semiconductor ETFs
A Wall Street Journal analysis, citing FactSet data, indicates that large-cap pharmaceutical and health insurance stocks have moved into negative correlation with semiconductor exchange-traded funds i
-
Analysis suggests that the State Street SPDR S&P Biotech ETF (XBI) is poised to outperform the iShares Global Healthcare ETF (IXJ) in 2026.
The analysis points out that while the iShares Global Healthcare ETF (IXJ) has performed better over the past five years, the State Street SPDR S&P Biotech ETF (XBI) has outperformed IXJ year-to-date,
-
US stock futures edge higher: Dow E-minis up 0.63%, S&P 500 E-minis up 0.49%, Nasdaq 100 E-minis up 0.53% amid Mideast deal hopes and healthcare M&A talks
U.S. stock index futures rose on Monday, August 3rd, with Dow E-minis up 0.63%, S&P 500 E-minis up 0.49%, and Nasdaq 100 E-minis up 0.53% as of 5:29 a.m. ET. This uplift was driven by signs of de-esca
-
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
A recent analysis compared the State Street Health Care Select Sector SPDR ETF (XLV) and the Invesco Nasdaq Biotechnology ETF (IBBQ), highlighting their differing risk-reward profiles. As of July 31,
-
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
An analysis article on Yahoo Finance compared two healthcare-themed ETFs: the State Street Health Care Select Sector SPDR ETF (XLV) and the Invesco Biotechnology & Genome ETF (PBE). The analysis noted
-
The analysis notes that the Fidelity Healthcare ETF (FHLC) is recommended as a better investment choice than the iShares Healthcare ETF (IYH) due to its lower fees and superior historical performance.
A Yahoo Finance analysis article notes that, against the backdrop of strong performance by healthcare stocks this year, the Fidelity MSCI Health Care Index ETF (FHLC) is recommended as a better invest
-
Piper Sandler warns that the "Magnificent Seven" rally "may be over" and is shifting its focus to the healthcare and financial sectors
Craig Johnson, chief market technologist at investment bank Piper Sandler, said that the rally in “Magnificent Seven” stocks “may be over” and that the market is shifting toward the healthcare and fin
-
The company plans to expand into the healthcare and biology sectors, positioning medical research as a significant opportunity for AI
Anthropic highlighted the immense potential of AI in healthcare in its IPO filing, including aiding in the treatment of major diseases and accelerating scientific discovery. The company plans to expan
-
According to the Financial Times, U.S. healthcare provider Bon Secours Mercy Health is in advanced talks to acquire a majority stake in Surgery Partners for approximately $6 billion, valuing the latter at around $20 per share.
According to the Financial Times, U.S. healthcare provider Bon Secours Mercy Health is in advanced talks to acquire a majority stake in Surgery Partners for approximately $6 billion, valuing the latte
-
Elevance Health Inc. (ELV) Q3 Earnings Report: EPS of $6.99 beats expectations, revenue of $50.44 billion beats expectations.
EPS: $6.99, market expected $4.71 Revenue: $50.44 billion, market expected $49.22 billion Reporting Period: FY2026 Q3 (ended September 30, 2026) Release Date: October 21, 2026
-
Steris to Acquire Xodus Medical for $2.1 Billion
Dublin, Ireland-based Steris, a provider of products and services to hospitals and pharmaceutical manufacturers, announced its plan to acquire Xodus Medical for $2.1 billion. The company expects the d
-
BlackRock Strategist Gargi Pal Chaudhuri Opposes Fed Hike, Recommends AI, Quality, and Healthcare Themes
BlackRock strategist Gargi Pal Chaudhuri recommends investors stay invested in the artificial-intelligence sector but broaden into themes like quality and healthcare.
-
Yahoo Finance Analysis: State Street XLV Outperforms iShares IXJ in Returns, Offers Lower Fees Despite Less Diversification
Yahoo Finance analysis indicates that the State Street Health Care Select Sector SPDR ETF (XLV), focusing on U.S. healthcare leaders, has outperformed the iShares Global Healthcare ETF (IXJ) in both o
-
Yahoo Finance Analysis: Bristol Myers Squibb (BMY) is a solid buy among healthcare stocks, with a forward yield nearing 4%, as patent cliff fears are deemed overblown.
The analysis notes that despite a major patent cliff, with Eliquis and Opdivo losing U.S. patent exclusivity in 2028, Bristol Myers Squibb's stock appears cheap at under 10 times forward earnings. Ana
-
U.S. Senator Elizabeth Warren's 2026 Bill Proposes Up to 6 Years in Prison for Private Equity Execs Over Patient Deaths
The Corporate Crimes Against Health Care Act of 2026, introduced by Senator Elizabeth Warren and other Democratic lawmakers in February, aims to hold private equity executives criminally liable for fi
-
Advent International seeks more Australia, New Zealand healthcare opportunities after acquiring New Zealand Clinical Research, valued at about $715 million
Advent International seeks more Australia, New Zealand healthcare opportunities after acquiring New Zealand Clinical Research, valued at about $715 million
-
OpenAI's ChatGPT Health Integrates with Epic EHR System
The integration allows clinicians to import patient data for AI queries, providing read-only access to health records without AI writing anything back. This enables clinicians to easily access and sum
-
Asian Healthcare Deals Heat Up as Investors Bet on Brain-Computer Interface and Surgical Robotics Technologies
Asian private investors, including Hong Kong family offices, are increasingly focusing on advanced medical technologies such as brain-computer interfaces and surgical robots. With the booming biotechn
-
Analysis indicates that the Fidelity MSCI Health Care Index ETF (FHLC) has lower fees and is more diversified, while the Invesco Pharmaceuticals ETF (PJP) has shown higher returns in recent years but carries concentrated risk.
An analysis article compared two healthcare ETFs. FHLC tracks a broad range of U.S. healthcare stocks, has lower fees than PJP, and offers a higher dividend yield, with over 300 stock holdings, making
-
Healthcare Stocks Increasingly Trade Opposite to Tech, Showing Negative Correlation with Semiconductor ETFs
A Wall Street Journal analysis, citing FactSet data, indicates that large-cap pharmaceutical and health insurance stocks have moved into negative correlation with semiconductor exchange-traded funds i
-
Analysis suggests that the State Street SPDR S&P Biotech ETF (XBI) is poised to outperform the iShares Global Healthcare ETF (IXJ) in 2026.
The analysis points out that while the iShares Global Healthcare ETF (IXJ) has performed better over the past five years, the State Street SPDR S&P Biotech ETF (XBI) has outperformed IXJ year-to-date,
-
US stock futures edge higher: Dow E-minis up 0.63%, S&P 500 E-minis up 0.49%, Nasdaq 100 E-minis up 0.53% amid Mideast deal hopes and healthcare M&A talks
U.S. stock index futures rose on Monday, August 3rd, with Dow E-minis up 0.63%, S&P 500 E-minis up 0.49%, and Nasdaq 100 E-minis up 0.53% as of 5:29 a.m. ET. This uplift was driven by signs of de-esca
-
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
A recent analysis compared the State Street Health Care Select Sector SPDR ETF (XLV) and the Invesco Nasdaq Biotechnology ETF (IBBQ), highlighting their differing risk-reward profiles. As of July 31,
-
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
An analysis article on Yahoo Finance compared two healthcare-themed ETFs: the State Street Health Care Select Sector SPDR ETF (XLV) and the Invesco Biotechnology & Genome ETF (PBE). The analysis noted
-
The analysis notes that the Fidelity Healthcare ETF (FHLC) is recommended as a better investment choice than the iShares Healthcare ETF (IYH) due to its lower fees and superior historical performance.
A Yahoo Finance analysis article notes that, against the backdrop of strong performance by healthcare stocks this year, the Fidelity MSCI Health Care Index ETF (FHLC) is recommended as a better invest
-
Piper Sandler warns that the "Magnificent Seven" rally "may be over" and is shifting its focus to the healthcare and financial sectors
Craig Johnson, chief market technologist at investment bank Piper Sandler, said that the rally in “Magnificent Seven” stocks “may be over” and that the market is shifting toward the healthcare and fin
- No data
Healthcare
24H Trending
-
1
Samsung Electronics fell 5.99% from its previous close, now trading at ₩227,500.
-
2
Samsung Electronics is down 4.44% from its previous close, now trading at ₩231,250.
-
3
Cryptocurrency Investing for Beginners: A Guide to Buying and Asset Management
-
4
Former Aptos advisor "Buzz" leaves project, shifts meme marketing efforts to Meta stock
-
5
WOL Token: Current Status and Investment Considerations for World of Legends
-
6
Nikkei Asia: Iranian separatists intensify attacks and seize territory in response to a potential full-scale US assault.
-
7
The Federal Reserve maintained interest rates, with a 10-2 vote. Lisa Cook and Beth Hammack voted in favor of a rate hike.
-
8
FOR Token (ForTube) Issuance Price and Project Analysis
-
9
President Trump returns to Ohio, highlighting over $100 billion in private investment attracted to the state during his term.
-
10
A Boston office building was sold at a foreclosure auction for one-third of its 2019 price, representing a discount of approximately $546 million.
Markets Today
Recommended Reading

